查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386608

全球過敏診斷與治療市場：趨勢、預測與競爭分析（~2030 年）

Allergy Diagnostics and Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

過敏診斷和治療的趨勢和預測

預計2024年至2030年全球過敏診斷和治療市場規模將以6.5%的年複合成長率成長，到2030年將達到約554億美元。該市場的主要驅動力是兒童和老年人群過敏性疾病的增加、IDV 技術的日益採用以及診斷工具的改進。全球過敏診斷和治療市場前景廣闊，食品、吸入和藥品市場蘊藏商機。

過敏診斷和治療市場洞察

Lucintel 預測，消耗品診斷測試消耗品的消耗品的採用率不斷增加，消耗品預計將在預測期內實現最高成長。

在這個市場中，由於患者獲得治療的機會增加以及對藥物過敏的認知提高，藥物過敏預計將出現最高的成長。

由於過敏病例數量不斷增加以及該地區政府的良好配合措施，預計北美在預測期內仍將是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業有何影響？

目錄

第1章 執行摘要

第2章 全球過敏診斷與治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢與預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球過敏診斷和治療市場趨勢（2018-2023）和預測（2024-2030）
  • 按產品類型分類的全球過敏診斷和治療市場
    • 裝置
    • 消耗品
    • 服務
  • 按過敏原類型分類的全球過敏診斷和治療市場
    • 食品
    • 吸入
    • 藥品
  • 按測試類型分類的全球過敏診斷和治療市場
    • In vivo Test
    • In vitro Test
  • 全球過敏診斷與治療市場：依藥物類別
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-cholinergic
    • Immuno-modulators
    • Epinephrine

第4章 市場趨勢與預測分析：按地區（2018-2030）

  • 全球過敏診斷和治療市場按地區分類
  • 北美過敏診療市場
  • 歐洲過敏診斷與治療市場
  • 亞太過敏診斷及治療市場
  • 其他地區過敏診療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球過敏診斷和治療市場成長機會
    • 按過敏原類型分類的全球過敏診斷和治療市場成長機會
    • 按測試類型分類的全球過敏診斷和治療市場成長機會
    • 按藥物類別分類的全球過敏診斷和治療市場成長機會
    • 按地區分類的全球過敏診斷和治療市場成長機會
  • 全球過敏診療市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球過敏診療市場產能
    • 全球過敏診斷和治療市場的合併和收購
    • 認證和許可

第7章 主要企業概況

  • R-Biopharm
  • EUROIMMUN Medizinische Labordiagnostika
  • DASIT
  • AESKU
  • BioMerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics
簡介目錄

Allergy Diagnostics and Therapeutics Trends and Forecast

The future of the global allergy diagnostics and therapeutics market looks promising with opportunities in the food, inhaled, and drug markets. The global allergy diagnostics and therapeutics market is expected to reach an estimated $55.4 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing allergy disorders in children and geriatric population, growing adoption of IDV techniques, and improvement in diagnostic tools.

A more than 150-page report is developed to help in your business decisions.

Allergy Diagnostics and Therapeutics by Segment

The study includes a forecast for the global allergy diagnostics and therapeutics by product type, allergen type, test type, drug class, and region.

Allergy Diagnostics and Therapeutics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Allergy Diagnostics and Therapeutics Market by Allergen Type [Shipment Analysis by Value from 2018 to 2030]:

  • Food
  • Inhaled
  • Drug

Allergy Diagnostics and Therapeutics Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • In Vivo Test
  • In Vitro Test

Allergy Diagnostics and Therapeutics Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anti-Cholinergic
  • Immuno-Modulators
  • Epinephrine
  • Immunotherapy

Allergy Diagnostics and Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Allergy Diagnostics and Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies allergy diagnostics and therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the allergy diagnostics and therapeutics companies profiled in this report include-

  • R-Biopharm
  • Euroimmun Medizinische Labordiagnostika
  • Dasit
  • Aesku
  • Biomerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics

Allergy Diagnostics and Therapeutics Market Insights

Lucintel forecasts that consumables is expected to witness highest growth over the forecast period due to its increasing adoption in the diagnostic testing that makes it indispensable.

Within this market, drug allergies is expected to witness highest growth due to increasing access to treatment and rising awareness of drug allergies among patients.

North America will remain the largest region over the forecast period due to increasing incidences of allergy and favorable government initiatives in the region.

Features of the Global Allergy Diagnostics and Therapeutics Market

Market Size Estimates: Allergy diagnostics and therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Allergy diagnostics and therapeutics market size by various segments, such as by product type, allergen type, test type, drug class, and region in terms of value ($B).

Regional Analysis: Allergy diagnostics and therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, allergen types, test types, drug classes, and regions for the allergy diagnostics and therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the allergy diagnostics and therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the allergy diagnostics and therapeutics market size?

Answer: The global allergy diagnostics and therapeutics market is expected to reach an estimated $55.4 billion by 2030.

Q.2 What is the growth forecast for allergy diagnostics and therapeutics market?

Answer: The global allergy diagnostics and therapeutics market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the allergy diagnostics and therapeutics market?

Answer: The major drivers for this market are increasing allergy disorders in children and geriatric population, growing adoption of IDV techniques, and improvement in diagnostic tools.

Q4. What are the major segments for allergy diagnostics and therapeutics market?

Answer: The future of the allergy diagnostics and therapeutics market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key allergy diagnostics and therapeutics market companies?

Answer: Some of the key allergy diagnostics and therapeutics companies are as follows:

  • R-Biopharm
  • Euroimmun Medizinische Labordiagnostika
  • Dasit
  • Aesku
  • Biomerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics

Q6. Which allergy diagnostics and therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that consumables is expected to witness highest growth over the forecast period due to its increasing adoption in the diagnostic testing that makes it indispensable.

Q7. In allergy diagnostics and therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing incidences of allergy and favorable government initiatives in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the allergy diagnostics and therapeutics market by product type (instruments, consumables, and services), allergen type (food, inhaled, and drug), test type (in vivo test and in vitro test), drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anti-cholinergic, immuno-modulators, epinephrine, and immunotherapy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Allergy Diagnostics and Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Allergy Diagnostics and Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Allergy Diagnostics and Therapeutics Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Services
  • 3.4: Global Allergy Diagnostics and Therapeutics Market by Allergen Type
    • 3.4.1: Food
    • 3.4.2: Inhaled
    • 3.4.3: Drug
  • 3.5: Global Allergy Diagnostics and Therapeutics Market by Test Type
    • 3.5.1: In vivo Test
    • 3.5.2: In vitro Test
  • 3.6: Global Allergy Diagnostics and Therapeutics Market by Drug Class
    • 3.6.1: Antihistamines
    • 3.6.2: Decongestants
    • 3.6.3: Corticosteroids
    • 3.6.4: Mast Cell Stabilizers
    • 3.6.5: Leukotriene Inhibitors
    • 3.6.6: Nasal Anti-cholinergic
    • 3.6.7: Immuno-modulators
    • 3.6.8: Epinephrine

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Allergy Diagnostics and Therapeutics Market by Region
  • 4.2: North American Allergy Diagnostics and Therapeutics Market
    • 4.2.2: North American Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.3: European Allergy Diagnostics and Therapeutics Market
    • 4.3.1: European Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.3.2: European Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.4: APAC Allergy Diagnostics and Therapeutics Market
    • 4.4.1: APAC Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.4.2: APAC Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.5: ROW Allergy Diagnostics and Therapeutics Market
    • 4.5.1: ROW Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.5.2: ROW Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Allergen Type
    • 6.1.3: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Test Type
    • 6.1.4: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Drug Class
    • 6.1.5: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Allergy Diagnostics and Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Allergy Diagnostics and Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Allergy Diagnostics and Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: R-Biopharm
  • 7.2: EUROIMMUN Medizinische Labordiagnostika
  • 7.3: DASIT
  • 7.4: AESKU
  • 7.5: BioMerieux
  • 7.6: Thermo Fisher Scientific
  • 7.7: Stallergenes Greer
  • 7.8: Minaris Medical America
  • 7.9: Siemens Healthcare
  • 7.10: Omega Diagnostics